Who we are

Alopecia Areata: The shame and embarrassment of this disease devastates the lives of too many women and girls when treatments do not work. Since 2007 Bald Girls Do Lunch has connected with over 3,000 to restore self-confidence and conquer isolation. With requests for meet-ups in every state and beyond the USA, Bald Girls is answering the plea for women to find others for community and support. From intimate groups to style workshops to restoring her looks, BGDL puts women on the track to normalcy and living well with this disease. Learn more...

Global Skin Logo - International Alliance of Dermatology Patient Organizations

BGDL Facebook Page


FDA Approves Medication for Severe Alopecia Areata

June 17th, 2022 by Chassin
FDA Approves First Systemic Treatment for Alopecia Areata

Eli Lilly is the first pharmaceutical company to receive FDA approval for systemic treatment of severe, adult alopecia areata with JAK Inhibitor molecules. The medication, Olumiant (baricitinib), is taken orally once a day.

Two other pharmaceutical companies, Concert and Pfizer, are not far behind. Both will be seeking FDA approval for their treatments using JAKs at the conclusion of their clinical trials.

Concert’s trial is known as THRIVE AA-2.
Pfizer’s trial is known as ALLEGRO.